Role of Phenotypes of Circulating Tumor Cells in the Diagnosis and Treatment of Colorectal Cancer

References

• BrayF, FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Erratum: global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70(4):313. doi:10.3322/caac.21609
   Web of Science ®Google Scholar
• YehCC, HsiSC, ChuuCP, KaoYH. Synchronous triple carcinoma of the colon and rectum. World J Surg Oncol. 2013;11:66. doi:10.1186/1477-7819-11-6623497155
   PubMed Web of Science ®Google Scholar
• NicolazzoC, RaimondiC, GradiloneA, et al. Circulating tumor cells in right- and left-sided colorectal cancer. Cancers (Basel). 2019;11(8). doi:10.3390/cancers11081042
   Web of Science ®Google Scholar
• MasudaT, HayashiN, IguchiT, ItoS, EguchiH, MimoriK. Clinical and biological significance of circulating tumor cells in cancer. Mol Oncol. 2016;10(3):408–417. doi:10.1016/j.molonc.2016.01.01026899533
   PubMed Web of Science ®Google Scholar
• KemenyN. The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol. 2010;22(4):364–373. doi:10.1097/CCO.0b013e32833a6c8a20520544
   PubMed Web of Science ®Google Scholar
• HartkopfAD, WagnerP, WallwienerD, FehmT, RothmundR. Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer. Anticancer Res. 2011;31(3):979–984.21498725
   PubMed Web of Science ®Google Scholar
• SmerageJB, BarlowWE, HortobagyiGN, et al. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. J Clin Oncol. 2014;32(31):3483–3489. doi:10.1200/JCO.2014.56.256124888818
   PubMed Web of Science ®Google Scholar
• HardinghamJE, GroverP, WinterM, HewettPJ, PriceTJ, ThierryB. Detection and clinical significance of circulating tumor cells in colorectal cancer – 20 years of progress. Mol Med. 2015;21(Suppl1):S25–31. doi:10.2119/molmed.2015.0014926605644
   PubMed Web of Science ®Google Scholar
• TolJ, KoopmanM, MillerMC, et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol. 2010;21(5):1006–1012. doi:10.1093/annonc/mdp46319861577
   PubMed Web of Science ®Google Scholar
• WuF, ZhuJ, MaoY, LiX, HuB, ZhangD. Associations between the epithelial-mesenchymal transition phenotypes of circulating tumor cells and the clinicopathological features of patients with colorectal cancer. Dis Markers. 2017;2017:9474532. doi:10.1155/2017/947453229430076
   PubMed Web of Science ®Google Scholar
• WernerS, StenzlA, PantelK, TodenhöferT. Expression of epithelial mesenchymal transition and cancer stem cell markers in circulating tumor cells. Adv Exp Med Biol. 2017;994:205–228.28560676
   PubMed Web of Science ®Google Scholar
• SatelliA, MitraA, BrownleeZ, et al. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015;21(4):899–906. doi:10.1158/1078-0432.CCR-14-089425516888
   PubMed Web of Science ®Google Scholar
• MooneySM, TalebianV, JollyMK, et al. The GRHL2/ZEB feedback loop - a key axis in the regulation of EMT in breast cancer. J Cell Biochem. 2017;118(9):2559–2570. doi:10.1002/jcb.2597428266048
   PubMed Web of Science ®Google Scholar
• Li-T-T, LiuH, LiF-P, et al. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: relevance to therapy response. World J Gastroenterol. 2015;21(47):13259–13267. doi:10.3748/wjg.v21.i47.1325926715808
   PubMed Web of Science ®Google Scholar
• HuB, YangX-R, XuY, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-044225271081
   PubMed Web of Science ®Google Scholar
• AbdallahEA, BraunAC, FloresB, et al. The potential clinical implications of circulating tumor cells and circulating tumor microemboli in gastric cancer. Oncologist. 2019;24(9):e854–e863. doi:10.1634/theoncologist.2018-074130846515
   PubMed Web of Science ®Google Scholar
• WuS, LiuS, LiuZ, et al. Classification of circulating tumor cells by epithelial-mesenchymal transition markers. PLoS One. 2015;10(4):e0123976. doi:10.1371/journal.pone.012397625909322
   PubMed Web of Science ®Google Scholar
• QiLN, XiangBD, WuFX, et al. Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma. Cancer Res. 2018;78(16):4731–4744. doi:10.1158/0008-5472.CAN-17-245929915159
   PubMed Web of Science ®Google Scholar
• HouJ, GuoC, LyuG. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer. Colorectal Dis. 2020;22(5):581–587. doi:10.1111/codi.1492731868956
   PubMed Web of Science ®Google Scholar
• DenèveE, RiethdorfS, RamosJ, et al. Capture of viable circulating tumor cells in the liver of colorectal cancer patients. Clin Chem. 2013;59(9):1384–1392. doi:10.1373/clinchem.2013.20284623695297
   PubMed Web of Science ®Google Scholar
• ShimadaR, IinumaH, AkahaneT, HoriuchiA, WatanabeT. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes’ stage B and C colorectal cancer patients. Oncol Rep. 2012;27(4):947–953. doi:10.3892/or.2012.164922267181
   PubMed Web of Science ®Google Scholar
• AllardWJ, MateraJ, MillerMC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897–6904. doi:10.1158/1078-0432.CCR-04-037815501967
   PubMed Web of Science ®Google Scholar
• van DalumG, StamGJ, ScholtenLF, et al. Importance of circulating tumor cells in newly diagnosed colorectal cancer. Int J Oncol. 2015;46(3):1361–1368. doi:10.3892/ijo.2015.282425572133
   PubMed Web of Science ®Google Scholar
• BrennerH, KloorM, PoxCP. Colorectal cancer. Lancet. 2014;383(9927):1490–1502. doi:10.1016/S0140-6736(13)61649-924225001
   PubMed Web of Science ®Google Scholar
• GuJ, ChenN. Current status of rectal cancer treatment in China. Colorectal Dis. 2013;15(11):1345–1350. doi:10.1111/codi.1226923651350
   PubMed Web of Science ®Google Scholar
• LiW, ZhouX, HuangZ, et al. Laparoscopic surgery minimizes the release of circulating tumor cells compared to open surgery for hepatocellular carcinoma. Surg Endosc. 2015;29(11):3146–3153. doi:10.1007/s00464-014-4041-525539696
   PubMed Web of Science ®Google Scholar
• YinW, HanYM, LiZL, HuangZX, HuangL, ZhongXG. Clinical significance of perioperative EMT-CTC in rectal cancer patients receiving open/laparoscopic surgery. Neoplasma. 2020;67(5):1131–1138. doi:10.4149/neo_2020_190709N61132412772
   PubMed Web of Science ®Google Scholar
• WuCY, LeeCL, WuCF, et al. Circulating tumor cells as a tool of minimal residual disease can predict lung cancer recurrence: a longitudinal, prospective trial. Diagnostics (Basel). 2020;10(3):144.
   PubMedGoogle Scholar
• ZhongY, QiaoT, MaT, et al. Long-term outcome comparison between two specimen extraction approaches for middle rectum cancer: a Retrospective Study. Surg Innov. Epub 2021 Mar 31; doi:10.1177/15533506211006970
   Web of Science ®Google Scholar
• TangQ, ZhuY, XiongH, et al. Natural orifice specimen extraction surgery versus conventional laparoscopic-assisted resection in the treatment of colorectal cancer: a propensity-score matching study. Cancer Manag Res. 2021;13:2247–2257. doi:10.2147/CMAR.S29108533727861
   PubMed Web of Science ®Google Scholar